| Role of the PPAR-α agonist fenofibrate in severe pediatric burn. | |
| | |
MedLine Citation:
|
PMID: 22226866 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Fenofibrate is a peroxisome proliferator activated receptor alpha agonist that contains both pro and anti-inflammatory properties, and has been used in the treatment of dyslipidemia and diabetes for decades. Its receptors are expressed in the liver, skeletal muscle, cardiac, enteric, and renal cells, which allow it to provide systemic regulation of lipoprotein metabolism, fatty acid oxidation, and fatty acid transport. Hyperglycemia is a common complication found in the burn population because hepatic glucose production and catecholamine-mediated hepatic glycogenolysis are augmented. Insulin resistance occurs often in these patients and is associated with poor outcomes. In the pediatric burn population, fenofibrate has been found to ameliorate or decrease the number of hypoglycemic episodes when compared to management with insulin alone. Its mechanism of action is thought to involve an improvement in insulin signaling in skeletal muscle, as well as improvements in mitochondrial function, glucose oxidation, and insulin sensitivity. The long term use of fenofibrate in severely burned patients may improve hyperglycemia and insulin resistance, as well as improve wound healing, and reduce apoptosis, and oxidative stress. |
| | |
Authors:
|
Itoro E Elijah; Elisabet Børsheim; Dirk M Maybauer; Celeste C Finnerty; David N Herndon; Marc O Maybauer |
Related Documents
:
|
15294056 - Metabolic flexibility. 18342796 - From a glucocentric to a lipocentric approach towards metabolic syndrome. 21549686 - Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does n... 18813416 - Impact of metabolic syndrome's components on the development of cardiovascular disease ... 3660546 - Inactive ovaries in high-yielding dairy cows before service: aetiology and effect on co... 8370576 - Relation of cardiovascular risk factors to atherosclerosis in type iii hyperlipoprotein... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-6 |
Journal Detail:
|
Title: Burns : journal of the International Society for Burn Injuries Volume: - ISSN: 1879-1409 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8913178 Medline TA: Burns Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd and ISBI. All rights reserved. |
Affiliation:
|
Department of Surgery, The University of Texas Medical Branch and Shriners Burns Hospital for Children at Galveston, TX, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive...
Next Document: Paediatric injuries associated with the use of disposable barbecues: Are we finding ourselves in hot...